Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Nov;3(4):247-249.
doi: 10.1159/000457959. Epub 2017 Mar 22.

Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2

Affiliations

Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2

Lisa Zimmermann et al. Ocul Oncol Pathol. 2017 Nov.

Abstract

We present a 27-year-old male patient with neurofibromatosis type 2 (NF2), facial palsy, and lagophthalmos following acoustic neuroma removal and an impressing vascularized corneal tumor, which was excised. Histology showed a fibrous tumor with small vessels, and immunohistochemistry was positive for vimentin and negative for smooth muscle actin, S100, and GFAP. We assume a corneal myofibroma (keloid), which in this case rather represents a reactive lesion. This entity has not been described before in NF2 or in facial palsy-associated lagophthalmos in general.

Keywords: Corneal myofibroma; Keloid; Neurofibromatosis type 2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
A whitish tumor on the cornea of the left eye with multiple vessel tufts within the tumor stroma of a 27-year-old male patient with known neurofibromatosis type 2.
Fig. 2
Fig. 2
Histology showing hyperplastic, non-keratinizing corneal epithelium with metaplasia towards keratinizing epithelium and dense vascularized fibromatous tissue (hematoxylin-eosin, original magnification ×100).
Fig. 3
Fig. 3
Upper half: low-power magnification of the specimen with the fibrous tissue highlighted by bluish positivity for Masson trichrome (original magnification ×40). Lower half: high-power magnification of the tumor stroma with small blood vessels of the area highlighted by the square (Masson trichrome, original magnification ×200).
Fig. 4
Fig. 4
Mainly negative staining of tumor cells for smooth muscle actin, whilst adjacent vessels were positive (arrow).

References

    1. Evans DGR. Neurofibromatosis type 2 (NF2): a clinical and molecular review. Orphanet J Rare Dis. 2009;4:16. - PMC - PubMed
    1. Parry DM, Eldridge R, Kaiser-Kupfer MI, et al. Neurofibromatosis 2 (NF2): clinical characteristics of 63 affected individuals and clinical evidence for heterogeneity. Am J Med Genet. 1994;52:450–461. - PubMed
    1. McLaughlin ME, Pepin SM, Maccollin M, et al. Ocular pathologic findings of neurofibromatosis type 2. Arch Ophthalmol. 2007;125:389–394. - PubMed
    1. Bouzas EA, Freidlin V, Parry DM, et al. Lens opacities in neurofibromatosis 2: further significant correlations. Br J Ophthalmol. 1993;77:354–357. - PMC - PubMed
    1. Holbach LM, Font RL, Shivitz IA, Jones DB. Bilateral keloid-like myofibroblastic proliferations of the cornea in children. Ophthalmology. 1990;97:1188–1193. - PubMed

LinkOut - more resources